Key facts
- CORIT’s last known valuation is $13.5M (Dec 2022).
- It has raised $3.5M; the latest was Later Stage VC in Jan 2025.
- Notable investors include MedTech Innovator, Keiretsu Forum, Virginia Innovation Partnership Corporation, Virginia Venture Partners, Accelerator Venture Partners — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for CORIT
- ·The full record, as it builds
Funding rounds
No funding rounds for CORIT are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CORIT
Developer of a commercial medical device technology, intended to focus on a single-use surgical device to improve breathing. The company's device requires no expensive equipment to set up and helps to treat sleep disorders by delivering enough air pressure to a mask to keep upper airway passages open, preventing snoring and sleep apnea, enabling clinicians to perform turbinate reduction procedures, improving patient acceptance, and yielding a high reimbursement.
- Sector
- Healthcare
- HQ
- McLean, VA, United States
- Founded
- 2017
- Employees
- 2
- Website
- coritmedical.com/
- Ownership
- Privately Held (backing)
CORIT doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CORIT shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CORIT in its N-PORT filings yet. We sweep new filings monthly.